{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:31:21Z","timestamp":1791639081184,"version":"4.3.4"},"reference-count":59,"publisher":"Wiley","issue":"20","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":450,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Biochemistry"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:p>Human cytosolic thioredoxin reductase (TrxR), a homodimeric protein containing 1 selenocysteine and 1 FAD per subunit of 55\u2003kDa, catalyses the NADPH\u2010dependent reduction of thioredoxin disulfide and of numerous other oxidized cell constituents. As a general reducing enzyme with little substrate specificity, it also contributes to redox homeostasis and is involved in prevention, intervention and repair of damage caused by H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>\u2010based oxidative stress.<\/jats:p><jats:p>Being a selenite\u2010reducing enzyme as well as a selenol\u2010containing enzyme, human TrxR plays a central role in selenium (patho)physiology. Both dietary selenium deficiency and selenium oversupplementation, a lifestyle phenomenon of our time, appear to interfere with the activity of TrxR. Selenocysteine 496 of human TrxR is a major target of the anti\u2010rheumatic gold\u2010containing drug auranofin, the formal <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> for the stoichiometric inhibition being 4 n<jats:sc>m<\/jats:sc>. The hypothesis that TrxR and extracellular thioredoxin play a pathophysiologic role in chronic diseases such as rheumatoid arthritis, Sj\u00f6gren's syndrom, AIDS, and certain malignancies, is substantiated by biochemical, virological, and clinical evidence. Reduced thioredoxin acts as an autocrine growth factor in various tumour diseases, as a chemoattractant, and it synergises with interleukins 1 and 2. The effects of anti\u2010tumour drugs such as carmustine and cisplatin can be explained in part by the inhibition of TrxR. Consistently, high levels of the enzyme can support drug resistance.<\/jats:p><jats:p>TrxRs from different organisms such as <jats:italic>Escherichia coli<\/jats:italic>, <jats:italic>Mycobacterium leprae<\/jats:italic>, <jats:italic>Plasmodium falciparum<\/jats:italic>, <jats:italic>Drosophila melanogaster<\/jats:italic>, and man show a surprising diversity in their chemical mechanism of thioredoxin reduction. This is the basis for attempts to develop specific TrxR inhibitors as drugs against bacterial infections like leprosy and parasitic diseases like amebiasis and malaria.<\/jats:p>","DOI":"10.1046\/j.1432-1327.2000.01703.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T17:56:57Z","timestamp":1047405417000},"page":"6118-6125","source":"Crossref","is-referenced-by-count":334,"title":["Thioredoxin reductase as a pathophysiological factor and drug target"],"prefix":"10.1111","volume":"267","author":[{"given":"Katja","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Heiner","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01704.x"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01702.x"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01701.x"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3460001"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1179\/135100099101534936"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.8.3621"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(98)00270-1"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.3.1006"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.6146"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.8.4722"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.65.070196.000503"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.9.1657"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0353"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.17.10116"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1165"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22607"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.36.23039"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.32.19180"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0498-267"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)43889-6"},{"key":"e_1_2_12_22_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/intimm\/8.4.603","article-title":"Elevation of plasma thioredoxin levels in HIV\u2010infected individuals","volume":"8","author":"Nakamura H.","year":"1996","journal-title":"Int. Immunol."},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(97)00429-2"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.15.8581"},{"key":"e_1_2_12_25_2","first-page":"1176","article-title":"Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN\u20104","volume":"44","author":"Medina D.","year":"1984","journal-title":"Cancer Res."},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01003-w"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2480"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4781(94)90180-5"},{"key":"e_1_2_12_29_2","first-page":"539","article-title":"The thioredoxin\/thioredoxin reductase redox system and control of cell growth","volume":"6","author":"Powis G.","year":"1994","journal-title":"Oncol. Res."},{"key":"e_1_2_12_30_2","first-page":"675","article-title":"High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells","volume":"55","author":"Rubartelli A.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.21.8282"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.35.24522"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(96)00109-8"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004380050259"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)90816-4"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7914"},{"key":"e_1_2_12_37_2","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.4049\/jimmunol.147.11.3837","article-title":"Protective activity of adult T cell leukemia\u2010derived factor (ADF) against tumor necrosis factor\u2010dependent cytotoxicity on U937 cells","volume":"147","author":"Matsuda M.","year":"1991","journal-title":"J. Immunol."},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(97)00816-8"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(90)90199-N"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(99)00101-x"},{"key":"e_1_2_12_41_2","first-page":"857","article-title":"Disulfide reductases are destabilized by physiologic concentrations of NADPH","volume":"13","author":"Schirmer M.","year":"1999","journal-title":"Flavins Flavoproteins"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390509"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.32.20096"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/129.1.194"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.3.835"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.359"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(96)02694-1"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi982674g"},{"key":"e_1_2_12_50_2","first-page":"91","article-title":"Characterization of two E. histolytica proteins that inactivate reactive oxygen species","volume":"28","author":"Bruchhaus I.","year":"1997","journal-title":"Arch. Med. Res."},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3301217"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.37.26051"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi980754e"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.43.25604"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/biof.5520100219"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3085"},{"key":"e_1_2_12_57_2","first-page":"4293","article-title":"Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide","volume":"55","author":"Yokomizo A.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3320231"},{"key":"e_1_2_12_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199605000-00016"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.11.6493"}],"container-title":["European Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1432-1327.2000.01703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1432-1327.2000.01703.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:23:20Z","timestamp":1698729800000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1046\/j.1432-1327.2000.01703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":59,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1046\/j.1432-1327.2000.01703.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01703.x","archive":["Portico"],"relation":{},"ISSN":["0014-2956","1432-1033"],"issn-type":[{"value":"0014-2956","type":"print"},{"value":"1432-1033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}